Home › NCT06342453
CREATE: Art for Children With Cancer
CREATE: Clinical Research Examining the Arts as Targeted Elements in Childhood Cancer Care
Who can join
Ages 8 to 13 · All sexes
Full eligibility criteria
Inclusion Criteria: * Aged 8 to 13 years of age * Have been diagnosed with cancer of any type in the prior 12 months * Be English literate (we will amend this criterium when the study surveys are validated in Spanish). Parent/caregiver of child participant may be Spanish speaking * Physically and cognitively able to participate in creative arts * Expected to receive enough treatment at local site to participate in all four intervention sessions Exclusion Criteria: * Not English literate * Otherwise unable to complete study procedures
About the study
This clinical trial is being done to develop and test how well creative arts interventions (drawing, painting, making sculptures) compared to watching videos can affect symptoms and impact the quality of life in children with cancer. Creative arts mind-body interventions (CrA) are one type of complementary health interventions which have been associated with improved quality of life and reduced symptom burden among children with cancer. CrA is an ideal intervention for children with cancer due to the long hours spent in the hospital setting for treatments, the creativity and developmental focus of children, and their potential ability to communicate more easily through art than words. Researchers want to develop and test a CrA intervention to help improve symptoms and the quality of life of children with cancer.
What is being tested
- Art Therapy (procedure)
- Discussion (procedure)
- Media Intervention (other)
- Survey Administration (other)
Sponsor: OHSU Knight Cancer Institute · Participants: 72 · Started: Jun 4, 2024
Contact the study team
- Mia Nolting, BFA · Phone: 415-518-4686
Official record on ClinicalTrials.gov — NCT06342453
Locations in the U.S.
| Oregon | OHSU Knight Cancer Institute, Portland |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.